Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02508935
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
PBS | (2S,3S,4R)-N-OCTANOYL-1-[(ALPHA- D-GALACTOPYRANOSYL)OXY]-2-AMINO- OCTADECANE-3,4-DIOL | A,C | 1Z5L | 0.71 | |
IGC | N-[(1S,2R,3E)-1-({[ALPHA-D-GALACTOPYRANOSYL- (1->3)-BETA-D-GALACTOPYRANOSYL- (1->4)-BETA-D-GLUCOPYRANOSYL]OXY}METHYL)- 2-HYDROXYHEPTADEC-3-EN-1-YL]OCTANAMIDE | A,C | 2Q7Y | 0.73 | |
SFT | SULFOGALACTOCERAMIDE | A,B | 2BHI | 0.71 | |
GM2 | N-[(1S,2S)-2-HYDROXY-1-({[(2R,3R,4S,5S,6R)- 3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)TETRAHYDRO- 2H-PYRAN-2-YL]OXY}METHYL)OCTADECYL]OCTADECANAMIDE | A | 1GZP | 0.7 | |
SLT | 5-(ACETYLAMINO)-3,5-DIDEOXYNON- 2-ULOPYRANONOSYL-(2->3)-BETA-D- LYXO-HEXOPYRANOSYL-(1->4)HEXOPYRANOSE | A | 1S0I | 0.71 | |
SLT | 5-(ACETYLAMINO)-3,5-DIDEOXYNON- 2-ULOPYRANONOSYL-(2->3)-BETA-D- LYXO-HEXOPYRANOSYL-(1->4)HEXOPYRANOSE | A | 1Z4X | 0.71 | |
RAD | C49-METHYL RAPAMYCIN | A | 2FAP | 0.71 | |
RAD | C49-METHYL RAPAMYCIN | A | 1NSG | 0.71 | |
GM3 | N-{1-[(HEXOPYRANOSYLOXY)METHYL]- 2-HYDROXYNONADECYL}TETRACOSANAMIDE | A | 2BV7 | 0.7 | |
BID | BISTRAMIDE A | A | 2FXU | 0.76 | |
CNP | 2-PROPENYL-N-ACETYL-NEURAMIC ACID | A | 4SLI | 0.73 | |
RAP | RAPAMYCIN IMMUNOSUPPRESSANT DRUG | A | 2DG3 | 0.71 | |
RAP | RAPAMYCIN IMMUNOSUPPRESSANT DRUG | A | 1PBK | 0.71 | |
RAP | RAPAMYCIN IMMUNOSUPPRESSANT DRUG | 2 | 1Z58 | 0.71 | |
RAP | RAPAMYCIN IMMUNOSUPPRESSANT DRUG | A | 2DG9 | 0.71 | |
RAP | RAPAMYCIN IMMUNOSUPPRESSANT DRUG | A | 1C9H | 0.71 | |
RAP | RAPAMYCIN IMMUNOSUPPRESSANT DRUG | A | 1FKB | 0.71 | |
RAP | RAPAMYCIN IMMUNOSUPPRESSANT DRUG | A | 1FAP | 0.71 | |
RAP | RAPAMYCIN IMMUNOSUPPRESSANT DRUG | A | 1FKL | 0.71 | |
RAP | RAPAMYCIN IMMUNOSUPPRESSANT DRUG | A | 2DG4 | 0.71 | |
RAP | RAPAMYCIN IMMUNOSUPPRESSANT DRUG | A | 2VCD | 0.71 | |
AGH | N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]- 2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE | A | 1ZT4 | 0.71 | |
AGH | N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]- 2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE | A,C,E | 2PO6 | 0.71 | |
FK5 | 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN | A | 2FKE | 0.71 | |
FK5 | 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN | A | 1FKF | 0.71 | |
FK5 | 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN | A,B,C | 1TCO | 0.71 | |
FK5 | 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN | A,B | 1Q6I | 0.71 | |
FK5 | 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN | A | 1FKJ | 0.71 | |
FK5 | 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN | A,B | 2VN1 | 0.71 | |
FK5 | 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN | A | 1YAT | 0.71 | |
FK5 | 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN | A | 1BKF | 0.71 | |
818 | 18-HYDROXYASCOMYCIN | A | 1FKD | 0.72 |